Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Biopesticides Market

ID: MRFR/Agri/3662-HCR
200 Pages
Snehal Singh
Last Updated: April 28, 2026

Biopesticides Market Size, Share, Industry Trend & Analysis Research Report By Type (Bioherbicide, Bioinsecticide, Bio Fungicide), By Form (Liquid, Dry), By Application (Soil, Foliar, Seed), By Crop (Grain, Cereal, Oilseeds, Fruits, Vegetables) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biopesticides Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Construction, BY Application (USD Billion) | |
      1. 4.1.1 Crop Protection | |
      2. 4.1.2 Soil Treatment | |
      3. 4.1.3 Post-Harvest Management | |
      4. 4.1.4 Seed Treatment |
    2. 4.2 Construction, BY Formulation Type (USD Billion) | |
      1. 4.2.1 Liquid Formulation | |
      2. 4.2.2 Granular Formulation | |
      3. 4.2.3 Wettable Powder | |
      4. 4.2.4 Emulsifiable Concentrate |
    3. 4.3 Construction, BY Source (USD Billion) | |
      1. 4.3.1 Microbial | |
      2. 4.3.2 Botanical | |
      3. 4.3.3 Mineral | |
      4. 4.3.4 Synthetic |
    4. 4.4 Construction, BY End Use (USD Billion) | |
      1. 4.4.1 Agriculture | |
      2. 4.4.2 Horticulture | |
      3. 4.4.3 Forestry | |
      4. 4.4.4 Turf and Ornamental |
    5. 4.5 Construction, BY Mode of Action (USD Billion) | |
      1. 4.5.1 Contact | |
      2. 4.5.2 Systemic | |
      3. 4.5.3 Repellent | |
      4. 4.5.4 Antifeedant |
    6. 4.6 Construction, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Construction | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 BASF SE (DE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Bayer AG (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Syngenta AG (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 FMC Corporation (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Valent BioSciences LLC (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Certis USA LLC (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Koppert Biological Systems (NL) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Biobest Group NV (BE) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 AgraQuest Inc. (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY FORMULATION TYPE |
    8. 6.5 US MARKET ANALYSIS BY SOURCE |
    9. 6.6 US MARKET ANALYSIS BY END USE |
    10. 6.7 US MARKET ANALYSIS BY MODE OF ACTION |
    11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
    12. 6.9 CANADA MARKET ANALYSIS BY FORMULATION TYPE |
    13. 6.10 CANADA MARKET ANALYSIS BY SOURCE |
    14. 6.11 CANADA MARKET ANALYSIS BY END USE |
    15. 6.12 CANADA MARKET ANALYSIS BY MODE OF ACTION |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY FORMULATION TYPE |
    19. 6.16 GERMANY MARKET ANALYSIS BY SOURCE |
    20. 6.17 GERMANY MARKET ANALYSIS BY END USE |
    21. 6.18 GERMANY MARKET ANALYSIS BY MODE OF ACTION |
    22. 6.19 UK MARKET ANALYSIS BY APPLICATION |
    23. 6.20 UK MARKET ANALYSIS BY FORMULATION TYPE |
    24. 6.21 UK MARKET ANALYSIS BY SOURCE |
    25. 6.22 UK MARKET ANALYSIS BY END USE |
    26. 6.23 UK MARKET ANALYSIS BY MODE OF ACTION |
    27. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION |
    28. 6.25 FRANCE MARKET ANALYSIS BY FORMULATION TYPE |
    29. 6.26 FRANCE MARKET ANALYSIS BY SOURCE |
    30. 6.27 FRANCE MARKET ANALYSIS BY END USE |
    31. 6.28 FRANCE MARKET ANALYSIS BY MODE OF ACTION |
    32. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION |
    33. 6.30 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE |
    34. 6.31 RUSSIA MARKET ANALYSIS BY SOURCE |
    35. 6.32 RUSSIA MARKET ANALYSIS BY END USE |
    36. 6.33 RUSSIA MARKET ANALYSIS BY MODE OF ACTION |
    37. 6.34 ITALY MARKET ANALYSIS BY APPLICATION |
    38. 6.35 ITALY MARKET ANALYSIS BY FORMULATION TYPE |
    39. 6.36 ITALY MARKET ANALYSIS BY SOURCE |
    40. 6.37 ITALY MARKET ANALYSIS BY END USE |
    41. 6.38 ITALY MARKET ANALYSIS BY MODE OF ACTION |
    42. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION |
    43. 6.40 SPAIN MARKET ANALYSIS BY FORMULATION TYPE |
    44. 6.41 SPAIN MARKET ANALYSIS BY SOURCE |
    45. 6.42 SPAIN MARKET ANALYSIS BY END USE |
    46. 6.43 SPAIN MARKET ANALYSIS BY MODE OF ACTION |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY SOURCE |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY END USE |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY MODE OF ACTION |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY APPLICATION |
    54. 6.51 CHINA MARKET ANALYSIS BY FORMULATION TYPE |
    55. 6.52 CHINA MARKET ANALYSIS BY SOURCE |
    56. 6.53 CHINA MARKET ANALYSIS BY END USE |
    57. 6.54 CHINA MARKET ANALYSIS BY MODE OF ACTION |
    58. 6.55 INDIA MARKET ANALYSIS BY APPLICATION |
    59. 6.56 INDIA MARKET ANALYSIS BY FORMULATION TYPE |
    60. 6.57 INDIA MARKET ANALYSIS BY SOURCE |
    61. 6.58 INDIA MARKET ANALYSIS BY END USE |
    62. 6.59 INDIA MARKET ANALYSIS BY MODE OF ACTION |
    63. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION |
    64. 6.61 JAPAN MARKET ANALYSIS BY FORMULATION TYPE |
    65. 6.62 JAPAN MARKET ANALYSIS BY SOURCE |
    66. 6.63 JAPAN MARKET ANALYSIS BY END USE |
    67. 6.64 JAPAN MARKET ANALYSIS BY MODE OF ACTION |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY SOURCE |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY END USE |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY MODE OF ACTION |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY SOURCE |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY END USE |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY MODE OF ACTION |
    78. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION |
    79. 6.76 THAILAND MARKET ANALYSIS BY FORMULATION TYPE |
    80. 6.77 THAILAND MARKET ANALYSIS BY SOURCE |
    81. 6.78 THAILAND MARKET ANALYSIS BY END USE |
    82. 6.79 THAILAND MARKET ANALYSIS BY MODE OF ACTION |
    83. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION |
    84. 6.81 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE |
    85. 6.82 INDONESIA MARKET ANALYSIS BY SOURCE |
    86. 6.83 INDONESIA MARKET ANALYSIS BY END USE |
    87. 6.84 INDONESIA MARKET ANALYSIS BY MODE OF ACTION |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY SOURCE |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY END USE |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY MODE OF ACTION |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION |
    95. 6.92 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE |
    96. 6.93 BRAZIL MARKET ANALYSIS BY SOURCE |
    97. 6.94 BRAZIL MARKET ANALYSIS BY END USE |
    98. 6.95 BRAZIL MARKET ANALYSIS BY MODE OF ACTION |
    99. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION |
    100. 6.97 MEXICO MARKET ANALYSIS BY FORMULATION TYPE |
    101. 6.98 MEXICO MARKET ANALYSIS BY SOURCE |
    102. 6.99 MEXICO MARKET ANALYSIS BY END USE |
    103. 6.100 MEXICO MARKET ANALYSIS BY MODE OF ACTION |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY SOURCE |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY END USE |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY MODE OF ACTION |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF ACTION |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY SOURCE |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY MODE OF ACTION |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY SOURCE |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY MODE OF ACTION |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY SOURCE |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY END USE |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY MODE OF ACTION |
    130. 6.127 KEY BUYING CRITERIA OF CONSTRUCTION |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF CONSTRUCTION |
    133. 6.130 DRIVERS IMPACT ANALYSIS: CONSTRUCTION |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION |
    135. 6.132 SUPPLY / VALUE CHAIN: CONSTRUCTION |
    136. 6.133 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE) |
    137. 6.134 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    138. 6.135 CONSTRUCTION, BY FORMULATION TYPE, 2024 (% SHARE) |
    139. 6.136 CONSTRUCTION, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion) |
    140. 6.137 CONSTRUCTION, BY SOURCE, 2024 (% SHARE) |
    141. 6.138 CONSTRUCTION, BY SOURCE, 2024 TO 2035 (USD Billion) |
    142. 6.139 CONSTRUCTION, BY END USE, 2024 (% SHARE) |
    143. 6.140 CONSTRUCTION, BY END USE, 2024 TO 2035 (USD Billion) |
    144. 6.141 CONSTRUCTION, BY MODE OF ACTION, 2024 (% SHARE) |
    145. 6.142 CONSTRUCTION, BY MODE OF ACTION, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY FORMULATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY SOURCE, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USE, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY MODE OF ACTION, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Construction Market Segmentation

Construction By Application (USD Billion, 2025-2035)

  • Crop Protection
  • Soil Treatment
  • Post-Harvest Management
  • Seed Treatment

Construction By Formulation Type (USD Billion, 2025-2035)

  • Liquid Formulation
  • Granular Formulation
  • Wettable Powder
  • Emulsifiable Concentrate

Construction By Source (USD Billion, 2025-2035)

  • Microbial
  • Botanical
  • Mineral
  • Synthetic

Construction By End Use (USD Billion, 2025-2035)

  • Agriculture
  • Horticulture
  • Forestry
  • Turf and Ornamental

Construction By Mode of Action (USD Billion, 2025-2035)

  • Contact
  • Systemic
  • Repellent
  • Antifeedant

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions